查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
類器官市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按器官類型、應用、來源、類型和地理位置
市場調查報告書
商品編碼
1372515

類器官市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按器官類型、應用、來源、類型和地理位置

Organoids Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Organ Type, Application, Source, Type, and Geography
出版日期: | 出版商: The Insight Partners | 英文 190 Pages | 訂單完成後即時交付

價格

類器官市場預計將從2022年的25.07億美元成長到2030年的122.06億美元；預計2022 年至2030 年年複合成長率為21.9%。對腫瘤建模和生物庫的更高需求、個性化藥物的日益採用以及對開發動物測試模型替代品的日益關注推動了類器官市場的成長。類器官市場趨勢包括將類器官與器官晶片結合。

類器官是源自幹細胞的微小、自組織、3D組織培養物。這種培養物可以被精心設計來複製器官的大部分複雜性或表達其選定的方面，例如僅產生某些類型的細胞。類器官由幹細胞生長而成，這些細胞可以無限分裂並產生不同類型的細胞作為其後代的一部分。類器官的大小範圍從小於頭髮的寬度到五毫米。

許多在類器官市場營運的市場參與者和研究機構正在開發先進技術，以擴大其產品組合併增加其市場佔有率。以下提到了與類器官相關的一些最新進展：

2020 年 11 月，Cellesce Ltd. 與 Manchester BIOGEL 建立合作夥伴關係，開發全合成的非動物3D (3D) 支架，該支架可以模仿人體的生理環境，並能夠製造、擴大規模並提高重複性源自患者的類器官。

2020 年 11 月，Cellesce Ltd. 與 Manchester BIOGEL 建立合作夥伴關係，開發全合成的非動物3D (3D) 支架，該支架可以模仿人體的生理環境，並能夠製造、擴大規模並提高重複性源自患者的類器官。

因此，這一發展可能會在預測期內為類器官市場帶來新的趨勢。

對新藥和先進藥物不斷成長的需求正在推動藥物發現和研究的整體步伐。根據 ClinicalTrials.gov 統計，2020 年臨床試驗研究總數估計為 356,282 項。休布雷希特研究所最近的一項調查表明，類器官可以透過識別不太可能從該藥物中受益的患者來使昂貴的藥物更具成本效益。全球範圍內越來越多的臨床試驗預計將推動對先進醫療技術（包括類器官模型）的需求。

此外，藥物發現中的類器官不僅限於癌症，它們還用於其他疾病，例如囊性纖維化、多囊性腎病變、小頭畸形以及腸道和氣道傳染病。例如，類器官可以概括器官的特性，例如器官結構和功能。此外，類器官可以恢復組織或器官的原始遺傳和表觀遺傳狀態，使它們適合基因編輯。各種研究顯示了將 CRISPR-Cas9 技術與類器官結合的積極成果，這為囊性纖維化的突破提供了更多機會。根據2020 年發表的一項研究“基於CRISPR 的腺嘌呤編輯器糾正囊性纖維化類器官生物庫中的無義突變”，囊性纖維化類器官生物庫代表了664 名患者，其中約20%理論上能夠有效修復無義突變透過腺嘌呤鹼基編輯器在囊性纖維化跨膜導體受體中。儘管基因編輯類器官在一些動物模型中取得了一些成果，但其效率明顯較低，成功率不高。因此，研究和開發基因編輯類器官的安全性、長期穩定性和功能性的方法至關重要。

此外，COVID-19 大流行引發了開發人類肺類器官模型的需求。例如，MilliporeSigma 開發了 3dGRO 人類肺類器官培養系統，使研究人員能夠控制、存取和複製器官組織，以培養人類肺上皮類器官模型，從而有助於在研究過程中獲得積極和成功的結果。

因此，此類創新預計將為類器官市場的成長提供更重要的成長機會。

基於應用程式的見解

根據應用，類器官市場分為發育生物學、傳染病的疾病病理學、再生醫學、藥物毒性和功效測試、藥物發現和個人化醫療等。到 2022 年，發育生物學佔據最大的市場佔有率，藥物發現和個人化醫療預計在預測期內年複合成長率最高。

基於來源的見解

根據來源，類器官市場分為多能幹細胞和器官特異性成體幹細胞。多能幹細胞細分市場到 2022 年將佔據更大的市場佔有率，預計在預測期內年複合成長率將更高。

世界衛生組織（WHO）、美國人口普查局和美國國家醫學圖書館是在準備類器官市場報告時提到的一些主要的一手和二手來源。

基於類型的見解

根據類型，類器官市場分為儀器、消耗品和服務。 2022 年，消耗品領域將佔據更大的市場佔有率，預計在預測期內年複合成長率將更高。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 重要見解
  • 市場吸引力

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：類器官市場格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 歐洲PEST分析
    • 亞太地區 PEST 分析
    • 南美洲和中美洲 PEST 分析
    • 中東和非洲 PEST 分析

第 5 章：類器官市場 - 主要產業動態

  • 主要市場促進因素：
    • 對腫瘤建模和生物樣本庫的需求不斷成長
    • 擴大採用個人化藥物
    • 人們日益關注開發動物測試模型的替代方案
  • 主要市場限制：
    • 與將類器官涵蓋現有工作流程相關的問題
    • 缺乏熟練的專業人員
  • 主要市場機會：
    • 專注於藥物發現活動
  • 未來的趨勢：
    • 將類器官與器官晶片結合
  • 影響分析：

第 6 章：類器官市場 - 全球市場分析

  • 類器官市場收入，2022 - 2030

第 7 章：全球類器官市場 - 2030 年收入與預測 - 按器官類型

  • 概述
  • 2022 年和 2030 年按器官類型分類的類器官市場收入佔有率 (%)
  • 胃
  • 腸
  • 肝
  • 胰臟
  • 肺
  • 腦
  • 腎
  • 其他

第 8 章：全球類器官市場 - 2030 年收入與預測 -按應用

  • 概述
  • 類器官市場收入佔有率，按應用分類 2022 年和 2030 年 (%)
  • 發育生物學
  • 傳染病的疾病病理學
  • 再生醫學
  • 藥物毒性和藥效測試
  • 藥物發現與個人化醫療
  • 其他

第 9 章：全球類器官市場 - 收入和 2030 年預測 - 按來源

  • 概述
  • 2022 年及 2030 年類器官市場收入佔有率（按來源分類）
  • 多能幹細胞
  • 器官特異性成體幹細胞

第 10 章：全球類器官市場 - 收入和 2030 年預測 - 按類型

  • 概述
  • 類器官市場收入佔有率，按類型 2022 年和 2030 年 (%)
  • 儀器
  • 耗材
  • 服務

第 11 章：類器官市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：Covid-19 前後的影響

  • Covid-19 前後的影響

第 13 章：類器官市場產業格局

  • 概述
  • 市場上公司採取的成長策略，(%)
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 14 章：類器官市場、主要公司概況

  • STEMCELL Technologies Inc.
  • Cellesce Ltd
  • Hubrecht Organoid Technology
  • Definigen
  • Organoid Therapeutics
  • 3Dnamics Inc.
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero

第 15 章：附錄

  • 關於我們
  • 專業術語
Product Code: TIPRE00017616

The organoids market is expected to grow from US$ 2.507 billion in 2022 to US$ 12.206 billion by 2030; it is estimated to register a CAGR of 21.9% from 2022 to 2030. The higher demand for tumor modeling and biobanking, growing adoption of personalized drugs, and rising focus on developing alternatives for animal testing models drive the organoids market growth. The organoids market trends include combining organoids with organ-on-a-chip.

The organoids are tiny, self-organized, three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ or to express selected aspects of it, like producing only certain types of cells. Organoids grow from stem cells-cells that can divide indefinitely and produce different types of cells as part of their progeny. Organoids can range in size from less than the width of a hair to five millimeters.

Many market players and research institutes operating in the organoids market are developing advanced technologies to expand their product portfolios and increase their market shares. A few of the recent developments related to organoids are mentioned below:

In November 2020, Cellesce Ltd. entered a partnership with Manchester BIOGEL for the development of fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable the manufacture, scale up, and improved reproducibility of patient-derived organoids.

In November 2020, Cellesce Ltd. entered a partnership with Manchester BIOGEL for the development of fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable the manufacture, scale up, and improved reproducibility of patient-derived organoids.

Thus, the development is likely to introduce new trends in the organoids market during the forecast period.

The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.

Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ's original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study 'CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,' published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids' safety, long-term stability, and functionality.

Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research.

Thus, such innovations are expected to offer more significant growth opportunities for organoids market growth.

Application-Based Insights

Based on application, the organoids market is divided into developmental biology, disease pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. In 2022, the developmental biology held the largest share of the market and drug discovery & personalized medicine is anticipated to register the highest CAGR during the forecast period.

Source-Based Insights

Based on source, the organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.

The World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine are a few of the major primary and secondary sources referred to while preparing the report on the organoids market.

Type-Based Insights

Based on type, the organoids market is bifurcated into instruments, consumables, and services. The consumables segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the organoids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the organoids market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Organoids Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis

5. Organoids Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Growing Adoption of Personalized Drugs
    • 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
  • 5.2 Key Market Restraints:
    • 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities:
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends:
    • 5.4.1 Combining Organoid with Organ-On-A-Chip
  • 5.5 Impact Analysis:

6. Organoids Market - Global Market Analysis

  • 6.1 Organoids Market Revenue (US$ Mn), 2022 - 2030

7. Global Organoids Market - Revenue and Forecast to 2030 - by Organ Type

  • 7.1 Overview
  • 7.2 Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Intestine
    • 7.4.1 Overview
    • 7.4.2 Intestine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Liver
    • 7.5.1 Overview
    • 7.5.2 Liver: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pancreas
    • 7.6.1 Overview
    • 7.6.2 Pancreas: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Lung
    • 7.7.1 Overview
    • 7.7.2 Lung: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Brain
    • 7.8.1 Overview
    • 7.8.2 Brain: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Kidney
    • 7.9.1 Overview
    • 7.9.2 Kidney: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Organoids Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Developmental Biology
    • 8.3.1 Overview
    • 8.3.2 Developmental Biology: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Disease Pathology of Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Disease Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Regenerative Medicine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Drug Toxicity and Efficacy Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Drug Discovery and Personalized Medicine
    • 8.7.1 Overview
    • 8.7.2 Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Organoids Market - Revenue and Forecast to 2030 - by Source

  • 9.1 Overview
  • 9.2 Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • 9.3 Pluripotent Stem Cells
    • 9.3.1 Overview
    • 9.3.2 Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Organ-specific Adult Stem Cells
    • 9.4.1 Overview
    • 9.4.2 Organ-specific Adult Stem Cells: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Organoids Market - Revenue and Forecast to 2030 - by Type

  • 10.1 Overview
  • 10.2 Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • 10.3 Instruments
    • 10.3.1 Overview
    • 10.3.2 Instruments: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Consumables
    • 10.4.1 Overview
    • 10.4.2 Consumables: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Services
    • 10.5.1 Overview
    • 10.5.2 Services: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. Organoids Market - Geographical Analysis

  • 11.1 North America Organoids Market, Revenue And Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America Organoids Market, by Organ Type
    • 11.1.4 North America Organoids Market, by Application
    • 11.1.5 North America Organoids Market, by Source
    • 11.1.6 North America Organoids Market, by Type
    • 11.1.7 North America Organoids Market, by Country
      • 11.1.7.1 US
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.1.3 US Organoids Market, by Organ Type
        • 11.1.7.1.4 US Organoids Market, by Application
        • 11.1.7.1.5 US Organoids Market, by Source
        • 11.1.7.1.6 US Organoids Market, by Type
      • 11.1.7.2 Canada
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.2.3 Canada Organoids Market, by Organ Type
        • 11.1.7.2.4 Canada Organoids Market, by Application
        • 11.1.7.2.5 Canada Organoids Market, by Source
        • 11.1.7.2.6 Canada Organoids Market, by Type
      • 11.1.7.3 Mexico
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.3.3 Mexico Organoids Market, by Organ Type
        • 11.1.7.3.4 Mexico Organoids Market, by Application
        • 11.1.7.3.5 Mexico Organoids Market, by Source
        • 11.1.7.3.6 Mexico Organoids Market, by Type
  • 11.2 Europe Organoids Market, Revenue And Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe Organoids Market, by Organ Type
    • 11.2.4 Europe Organoids Market, by Application
    • 11.2.5 Europe Organoids Market, by Source
    • 11.2.6 Europe Organoids Market, by Type
    • 11.2.7 Europe Organoids Market by Country
      • 11.2.7.1 Germany
        • 11.2.7.1.1 Overview
        • 11.2.7.1.2 Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.1.3 Germany Organoids Market, by Organ Type
        • 11.2.7.1.4 Germany Organoids Market, by Application
        • 11.2.7.1.5 Germany Organoids Market, by Source
        • 11.2.7.1.6 Germany Organoids Market, by Type
      • 11.2.7.2 UK
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 UK Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.2.3 UK Organoids Market, by Organ Type
        • 11.2.7.2.4 UK Organoids Market, by Application
        • 11.2.7.2.5 UK Organoids Market, by Source
        • 11.2.7.2.6 UK Organoids Market, by Type
      • 11.2.7.3 France
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.3.3 France Organoids Market, by Organ Type
        • 11.2.7.3.4 France Organoids Market, by Application
        • 11.2.7.3.5 France Organoids Market, by Source
        • 11.2.7.3.6 France Organoids Market, by Type
      • 11.2.7.4 Italy
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.4.3 Italy Organoids Market, by Organ Type
        • 11.2.7.4.4 Italy Organoids Market, by Application
        • 11.2.7.4.5 Italy Organoids Market, by Source
        • 11.2.7.4.6 Italy Organoids Market, by Type
      • 11.2.7.5 Spain
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.5.3 Spain Organoids Market, by Organ Type
        • 11.2.7.5.4 Spain Organoids Market, by Application
        • 11.2.7.5.5 Spain Organoids Market, by Source
        • 11.2.7.5.6 Spain Organoids Market, by Type
      • 11.2.7.6 Rest of Europe
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.6.3 Rest of Europe Organoids Market, by Organ Type
        • 11.2.7.6.4 Rest of Europe Organoids Market, by Application
        • 11.2.7.6.5 Rest of Europe Organoids Market, by Source
        • 11.2.7.6.6 Rest of Europe Organoids Market, by Type
  • 11.3 Asia Pacific Organoids Market, Revenue And Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific Organoids Market, by Organ Type
    • 11.3.4 Asia Pacific Organoids Market, by Application
    • 11.3.5 Asia Pacific Organoids Market, by Source
    • 11.3.6 Asia Pacific Organoids Market, by Type
    • 11.3.7 Asia Pacific Organoids Market by Country
      • 11.3.7.1 China
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.1.3 China Organoids Market, by Organ Type
        • 11.3.7.1.4 China Organoids Market, by Application
        • 11.3.7.1.5 China Organoids Market, by Source
        • 11.3.7.1.6 China Organoids Market, by Type
      • 11.3.7.2 Japan
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.2.3 Japan Organoids Market, by Organ Type
        • 11.3.7.2.4 Japan Organoids Market, by Application
        • 11.3.7.2.5 Japan Organoids Market, by Source
        • 11.3.7.2.6 Japan Organoids Market, by Type
      • 11.3.7.3 India
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 India Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.3.3 India Organoids Market, by Organ Type
        • 11.3.7.3.4 India Organoids Market, by Application
        • 11.3.7.3.5 India Organoids Market, by Source
        • 11.3.7.3.6 India Organoids Market, by Type
      • 11.3.7.4 Australia
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.4.3 Australia Organoids Market, by Organ Type
        • 11.3.7.4.4 Australia Organoids Market, by Application
        • 11.3.7.4.5 Australia Organoids Market, by Source
        • 11.3.7.4.6 Australia Organoids Market, by Type
      • 11.3.7.5 South Korea
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.5.3 South Korea Organoids Market, by Organ Type
        • 11.3.7.5.4 South Korea Organoids Market, by Application
        • 11.3.7.5.5 South Korea Organoids Market, by Source
        • 11.3.7.5.6 South Korea Organoids Market, by Type
      • 11.3.7.6 Rest of Asia Pacific
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.6.3 Rest of Asia Pacific Organoids Market, by Organ Type
        • 11.3.7.6.4 Rest of Asia Pacific Organoids Market, by Application
        • 11.3.7.6.5 Rest of Asia Pacific Organoids Market, by Source
        • 11.3.7.6.6 Rest of Asia Pacific Organoids Market, by Type
  • 11.4 Middle East & Africa Organoids Market, Revenue and Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa Organoids Market, by Organ Type
    • 11.4.4 Middle East & Africa Organoids Market, by Application
    • 11.4.5 Middle East & Africa Organoids Market, by Source
    • 11.4.6 Middle East & Africa Organoids Market, by Type
    • 11.4.7 Middle East & Africa Organoids Market by Country
      • 11.4.7.1 Saudi Arabia
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.1.3 Saudi Arabia Organoids Market, by Organ Type
        • 11.4.7.1.4 Saudi Arabia Organoids Market, by Application
        • 11.4.7.1.5 Saudi Arabia Organoids Market, by Source
        • 11.4.7.1.6 Saudi Arabia Organoids Market, by Type
      • 11.4.7.2 UAE
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.2.3 UAE Organoids Market, by Organ Type
        • 11.4.7.2.4 UAE Organoids Market, by Application
        • 11.4.7.2.5 UAE Organoids Market, by Source
        • 11.4.7.2.6 UAE Organoids Market, by Type
      • 11.4.7.3 South Africa
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.3.3 South Africa Organoids Market, by Organ Type
        • 11.4.7.3.4 South Africa Organoids Market, by Application
        • 11.4.7.3.5 South Africa Organoids Market, by Source
        • 11.4.7.3.6 South Africa Organoids Market, by Type
      • 11.4.7.4 Rest of Middle East & Africa
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.4.3 Rest of Middle East & Africa Organoids Market, by Organ Type
        • 11.4.7.4.4 Rest of Middle East & Africa Organoids Market, by Application
        • 11.4.7.4.5 Rest of Middle East & Africa Organoids Market, by Source
        • 11.4.7.4.6 Rest of Middle East & Africa Organoids Market, by Type
  • 11.5 South & Central America Organoids Market, Revenue and Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America Organoids Market, by Organ Type
    • 11.5.4 South & Central America Organoids Market, by Application
    • 11.5.5 South & Central America Organoids Market, by Source
    • 11.5.6 South & Central America Organoids Market, by Type
    • 11.5.7 South & Central America Organoids Market by Country
      • 11.5.7.1 Brazil
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.1.3 Brazil Organoids Market, by Organ Type
        • 11.5.7.1.4 Brazil Organoids Market, by Application
        • 11.5.7.1.5 Brazil Organoids Market, by Source
        • 11.5.7.1.6 Brazil Organoids Market, by Type
      • 11.5.7.2 Argentina
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.2.3 Argentina Organoids Market, by Organ Type
        • 11.5.7.2.4 Argentina Organoids Market, by Application
        • 11.5.7.2.5 Argentina Organoids Market, by Source
        • 11.5.7.2.6 Argentina Organoids Market, by Type
      • 11.5.7.3 Rest of South & Central America
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.3.3 Rest of South & Central America Organoids Market, by Organ Type
        • 11.5.7.3.4 Rest of South & Central America Organoids Market, by Application
        • 11.5.7.3.5 Rest of South & Central America Organoids Market, by Source
        • 11.5.7.3.6 Rest of South & Central America Organoids Market, by Type

12. Pre & Post Covid-19 Impact

  • 12.1 Pre & Post Covid-19 Impact

13. Organoids Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Organoids Market, Key Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Cellesce Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Hubrecht Organoid Technology
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Definigen
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Organoid Therapeutics
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 3Dnamics Inc.
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Thermo Fisher Scientific Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Corning Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Merck KGaA
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 InSphero
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Organoids Market Segmentation
  • Table 2. North America Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 3. North America Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Application
  • Table 4. North America Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Source
  • Table 5. North America Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 6. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 7. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 8. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 9. US Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 10. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 11. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 12. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 13. Canada Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 14. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 15. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 16. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 17. Mexico Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 18. Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 19. Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Application
  • Table 20. Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Source
  • Table 21. Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 22. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 23. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 24. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 25. Germany Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 26. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 27. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 28. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 29. UK Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 30. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 31. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 32. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 33. France Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 34. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 35. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 36. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 37. Italy Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 38. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 39. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 40. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 41. Spain Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 42. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 43. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 44. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 45. Rest of Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 46. Asia Pacific Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 47. Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Application
  • Table 48. Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Source
  • Table 49. Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 50. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 51. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 52. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 53. China Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 54. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 55. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 56. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 57. Japan Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 58. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 59. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 60. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 61. India Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 62. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 63. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 64. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 65. Australia Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 66. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 67. South Korea Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 68. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 69. South Korea Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 70. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) -Organ Type
  • Table 71. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 72. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) Source
  • Table 73. Rest of Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 74. Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 75. Middle East & Africa Organoids Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 76. Middle East & Africa Organoids Market Revenue and Forecast To 2030 (US$ Mn) - Source
  • Table 77. Middle East & Africa Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 78. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 79. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 80. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 81. Saudi Arabia Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 82. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 83. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 84. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 85. UAE Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 86. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 87. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 88. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 89. South Africa Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 90. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 91. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 92. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 93. Rest of Middle East & Africa Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 94. South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 95. South & Central America Organoids Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 96. South & Central America Organoids Market Revenue and Forecast To 2030 (US$ Mn) - Source
  • Table 97. South & Central America Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 98. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 99. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 100. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 101. Brazil Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 102. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 103. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 104. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 105. Argentina Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 106. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 107. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 108. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 109. Rest of South & Central America Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 110. Organic Developments Done by Companies
  • Table 111. Inorganic Developments Done by Companies
  • Table 112. Glossary of Terms, Organoids Market

List Of Figures

  • Figure 1. Organoids Market Segmentation, By Geography
  • Figure 2. North America - PEST Analysis
  • Figure 3. Europe - PEST Analysis
  • Figure 4. Asia Pacific - PEST Analysis
  • Figure 5. South & Central America - PEST Analysis
  • Figure 6. Middle East & Africa - PEST Analysis
  • Figure 7. Organoids Market - Key Industry Dynamics
  • Figure 8. Impact Analysis of Drivers and Restraints
  • Figure 9. Organoids Market Revenue (US$ Mn), 2022 - 2030
  • Figure 10. Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • Figure 11. Stomach: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Intestine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Liver: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Pancreas: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Lung: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Brain: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Kidney: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 20. Developmental Biology: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Disease Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Regenerative Medicine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Others: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 27. Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Organ-specific Adult Stem Cells: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 30. Instruments: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Consumables: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Services: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Organoids Market, 2022 ($Mn)
  • Figure 34. North America Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 35. North America Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 36. US Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 37. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 39. Europe Organoids Market, By Geography, 2022 ($Mn)
  • Figure 40. Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 41. Europe Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 42. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 43. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. France Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 45. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 46. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 48. Organoids Market, By Geography, 2022 ($Mn)
  • Figure 49. Asia Pacific Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 50. Asia Pacific Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 51. China Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 52. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 53. India Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 54. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 55. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. Organoids Market, By Geography, 2022 And 2030 ($Mn)
  • Figure 58. Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Middle East & Africa Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 60. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 62. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 63. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 64. Organoids Market, By Geography, 2022 ($Mn)
  • Figure 65. South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 66. South & Central America Organoids Market, By Key Countries, 2022 and 2030 (%)
  • Figure 67. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 68. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 69. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 70. Pre & Post Covid-19 Impact
  • Figure 71. Growth Strategies Done by the Companies in the Market, (%)